Meeting daily compliance in PharmaOperations

Size: px
Start display at page:

Download "Meeting daily compliance in PharmaOperations"

Transcription

1 Meeting daily compliance in PharmaOperations SKMF Spring Event 2012 Dr. Peter Hess

2 Themenübersicht Compliance Framework GMP Activities and compliance documentation in a production plant Compliance preconditions «The way» to compliance Intangible assets and value creation The missink link

3 Pharma Compliance in the Press Reuters, Dec 6, 2011: FDA cites violations at three Novartis plants (Reuters) -Drug regulators cited Novartis AG for "significant violations" of manufacturing regulations at its three generic drug plants in the United States and Canada, several of which were repeat offenses. "We are concerned that your firm lacks process understanding to consistently manufacture", FDA wrote in the letter dated November 18. US department of Health & Services/FDA; Jan : Novartis is voluntarily recalling all lots of two products / Novartis commitment to quality Novartis Consumer Health, Inc. (NCH) announced today that it is voluntarily recalling all lots of select bottle packaging configurations of Excedrin and NoDoz products because the products may contain stray tablets, capsules, or caplets from other Novartis products, or contain broken or chipped tablets. The Novartis Group is fully committed to ensuring the quality, safety and integrity of its products. All Novartis Group companies have a clear commitment to patients and Health Authorities to ensure high quality standards for all our products and services. Pharma Manufacturing Newsletter February 6, 2012: FDA report shows deep problems at closed Novartis Consumer Health plant. Novartis has set aside $120 million to address shortcomings at the plant and CEO Joseph Jimenez has told the investment community he is confident the plant will reopen mid-year.

4 Compliance Framework in the Pharma Industry Ultimate goals of compliance: Safeguarding the health of the patient as well as producing good quality medicine, medical devices or active pharmaceutical products. cgmp (CurrentGood Manufacturing Practice): Main mandatory regulation for Pharma Industry anchored in the US federal Food, Drug, and Cosmetic (FD&C) Act and EudraLex Volume 4 in EU. "GMP" -A set of principles and procedures which, when followed by manufacturers for therapeutic goods, helps ensure that the products manufactured will have the required quality. A basic tenet of cgmp is that quality must be built into each batch of product during all stages of the manufacturing process. cgmp is that part of Quality Assurance aimed at ensuring that products are consistently manufactured to a quality appropriate to their intended use Compliance Monitoring & Enforcement: Inspections performed by national Regulatory Agencies like CH: Swissmedic, US: FDA, EU: DG Health & Consumers). Regulatory agencies are authorized to conduct unannounced inspections at any time the firms are open for business.

5 GMP covers. ALLaspects of production; from the starting materials, premises and equipment to the training and personal hygiene of staff. Documents: Detailed, written procedures are essential for each process that could affect the quality of the finished product. Document Management: There must be systems to provide documented proof that correct procedures are consistently followed at each step in the manufacturing process -every time a product is made. Quality management system (QMS): Each company has to create own individual QMS which integrates cgmp requeirements but covers and integrates manyother (national) regulations, quidelines, internal policies. Qualification requirements ( ): Each person engaged or responsible for supervising in the manufacture, processing, packing, or holding of a drug product shall have education, training, and experience, or any combination thereof, to enable that person to perform the assigned functions. Management approach: «The parameters and requirements to achieve compliance are given, let s do it «How do companies manage all that know-how Dr. Hess Interim How can Management all employees know at any time what and how to do Umfassende Kompetenz Responsibilities in Logistik und Produktion and

6 Compliance Management Systems But: is that all.?

7 Overview activities in production plant Synthesis of final Product (API) : Several chemical stages required Products are manufactured in campaigns with multiple product lines configured to operate simultaneously. Parallel to the production: cleaning (product change), maintenance (repair, qualification, calibration). Summary: Dozens of different activities take place at the same time. A single stage SM1 IP1 SM2 API KI IP2 SM3 Handling Loading Process Work Up Isolation Sampling dispensing weighing of materials Solvents reagents intermediates chemical reaction step quench evaporation filtration extraction/ phase separation crystallisation filtration centrifugation drying milling sieving blending

8 Compliance: Overview important documents Regulated Areas Activities Documentation Buildings Infrastructure Process Equipment Control Systems Documentation Hygiene Manufacturing Utilities Tank Farm Warehouse QC Personel Security & Safety Process work Monitoring Cleaning Validation Calibration Qualification Sampling Staff Training Policies SOP Specifications Master Formula Record Batch MR Manuals Master plans/ files Validation protocols Forms and Formats Records Policies SOP Specifications MFR (Master Formula Record) Batch MR Manuals Master plans/ files Validation protocols Forms Policies SOP Specifications Master Formula Record Batch MR Manuals Master plans/ files Validation protocols Forms and Formats Records How can all employees know at any time what and how to do?

9 Compliance Preconditions Novartis non-compliance?? GMP Compliance Compliance happens all the time, everywhere with every action: How can a plant manager guarantee and account for compliance relying on many Individuals? How to achieve compliance? Zero Error Culture Operational Excellence Something missing? Experience, Further learning Training on the job, SOP s, Practical GMP-raining GMP Theory, Company Guidelines, Education All management & staff levels Willngness Ability Knowledge Information

10 The «way» to compliance «Complience Rules» «The Way» Enforcement? Empowerment? Control? Trust? «The Goal»???

11 The «way» to compliance «Complience Rules» «The Way»?

12 The «way» to compliance «Complience Rules» «The Way»?

13 The «way» to compliance «Complience Rules» «The Way»?

14 Intangible assets and value creation Goal of Knowledge Management*) «A systematic approach to find, understand, share and use knowledge to cretae value» Pharmaceutical industry Knowledge based organizations with focus on operational excellence (= processes, quality & costs) use best practice by sharing knowledge Individual / intangible Assets = The true foundation of value creation are the intangible assets of the companies = Knowledge and Abilities of the managers, middle managers and frontline employees Leadership Willingness and Motivation Value Creation The ability to craete value depends not on written proceders and quiedelines, but on the willingens and motivation of individuals to focus on their daily work, to reach their daily goals and all compliance requierements *) Carla O'dell, C. Jackson Grayson, If Only We Knew What We Know, pioneers in Knowledge Management

15 Summary: The missing link The ability to craete value depends not on written proceders and quiedelines, but on the willingness of individuals to focus on their daily work, to reach their daily goals and all compliance requierements GMP Compliance Zero Defect Culture Operational Excellence Skills, Behavior, Cultur Experience, Learning Training on the job, SOP s, Practical Training The ultimate driver for business success i.e. compliance is to transform knowledge and ability into willingness and motivation of each individual and his performance Motivation Ability Knowledge Company Guidelines, Education, GMP Theory, Information

16 The most ancient and simple compliance approach! Epicurus, BC, is one of the well known writers of antiquity. The central point of his thinking was linked to the question: On what relies the happiness of the wise man? Epicurus replies (fully in the meaning of GMPcompliance): The wise man arranges his life according to rules to relieve him from of fear, pain and desire

17 Vielen Dank! Fragen?

MeriCal Quality Profile

MeriCal Quality Profile January 5, 2015 Dear Valued Customer, Since the implementation of new federal regulations, MeriCal Inc. has received a large volume of questionnaires and surveys regarding our services and procedures.

More information

NEW CHEMICAL ENTITIES

NEW CHEMICAL ENTITIES NEW CHEMICAL ENTITIES PIONEERING PARTNER FOR PEPTIDES With more than 40 years of expertise in peptide synthesis, a track record in process development, large-scale manufacturing and outstanding product

More information

Extemporaneously Prepared Early Phase Clinical Trial Materials

Extemporaneously Prepared Early Phase Clinical Trial Materials Extemporaneously Prepared Early Phase Clinical Trial Materials Richard Hoffman, MS, RAC Eli Lilly & Co. Regulatory Advisor International Consortium for Innovation & Quality in Pharmaceutical Development

More information

Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE

Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE Dr. Fulvio CARLOTTI, GNOSIS SpA, Corporate QA Director September 26, 2014 Scope of GMP GMP compliance

More information

Guidelines for drafting a Site Master File (SMF)

Guidelines for drafting a Site Master File (SMF) Guidelines for drafting a Site Master File (SMF) A Site Master File for each manufacturing site listed in a product dossier, must be submitted to World Health Organization, HTP/EDM/QSM, 20 Ave Appia, 1211

More information

Combination Products. Presented by: Karen S. Ginsbury For: IFF March 2014. PCI Pharma

Combination Products. Presented by: Karen S. Ginsbury For: IFF March 2014. PCI Pharma Combination Products Presented by: Karen S. Ginsbury For: IFF March 2014 Types of products Biological and medical device (freeze dried + syringe dual volume) Medical device and plasma devised product (syringe)

More information

Quality Agreement. by and between. Supplier Name. Address: and. Client Name: Address:

Quality Agreement. by and between. Supplier Name. Address: and. Client Name: Address: NOTE TO USERS This Quality Agreement template was developed by the Bulk Pharmaceutical Task Force (BPTF), an affiliate organization of the Society of Chemical Manufacturers and Affiliates (SOCMA), as a

More information

Pharmaceutical Quality Systems: US Perspective

Pharmaceutical Quality Systems: US Perspective Pharmaceutical Quality Systems: US Perspective Rick Friedman Associate Director, Office of Manufacturing and Product Quality Center for Drug Evaluation and Research Topics Background: The ICH Q10 Pharmaceutical

More information

2014 Annual Report on Inspections of Establishments

2014 Annual Report on Inspections of Establishments 2014 Annual Report on Inspections of Establishments Table of Contents Introduction... 2 Data Collection and Definitions... 3 Section 510(h)(6)(A)(i) Number of Domestic and Foreign Establishments Registered

More information

Audit Report in the framework of the APIC Audit Programme

Audit Report in the framework of the APIC Audit Programme Audit Report in the framework of the APIC Audit Programme Company Location Address Country Subject of Audit Audit Date Auditor (lead) Co-Auditor(s) Participants Signature of Auditor(s) Lead Auditor Co-Auditor

More information

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations Kevin O Donnell PhD Market Compliance Manager, IMB PDA / FDA Conference Pharmaceutical

More information

Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions

Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions WELCOME Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions Contents: Introduction GMP Audit GMP Audit plan GMP Auditing

More information

1. Scope This SOP covers requirements for PHARMCO-AAPER s Quality Management System

1. Scope This SOP covers requirements for PHARMCO-AAPER s Quality Management System Page 1 of 8 1. Scope This SOP covers requirements for PHARMCO-AAPER s Quality Management System 2. Application This Standard Operating Procedure applied to the entire Quality Management System as it relevant

More information

Auditing as a Component of a Pharmaceutical Quality System

Auditing as a Component of a Pharmaceutical Quality System Auditing as a Component of a Pharmaceutical Quality System Tim Fields Conducting internal audits (or self inspections) and external audits of suppliers and outsourcing operations are key elements of a

More information

Quality Assurance. Disclosure for Lilli Møller Andersen. No relevant financial relationships exist for any issue mentioned in this presentation

Quality Assurance. Disclosure for Lilli Møller Andersen. No relevant financial relationships exist for any issue mentioned in this presentation Quality Assurance Disclosure for Lilli Møller Andersen No relevant financial relationships exist for any issue mentioned in this presentation Agenda Quality Assurance Quality Management System Quality

More information

Life (or is it really?) Under a Consent Decree

Life (or is it really?) Under a Consent Decree Life (or is it really?) Under a Consent Decree Steven Niedelman Lead Quality Systems & Compliance Consultant King & Spalding LLP 1700 Pennsylvania Ave., NW Washington, DC 2006 202-626-2942 sniedelman@kslaw.com

More information

Sandoz Private Limited 10/22/15

Sandoz Private Limited 10/22/15 Sandoz Private Limited 10/22/15 Department of Health and Human Services Public Health Service Food and Drug Administration Silver Spring, MD 20993 Warning Letter VIA UPS WL: 320-16-01 October 22, 2015

More information

Welcome to the ChemCon Company Presentation: 6 Steps to Success for our Customers!

Welcome to the ChemCon Company Presentation: 6 Steps to Success for our Customers! Welcome to the ChemCon Company Presentation: 6 Steps to Success for our Customers! The Founder s Vision 1992: Dr. Peter Gockel develops synthesis routes of future Active Pharmaceutical Ingredients at the

More information

C 5. chemical development contract research custom synthesis cgmp API manufacturing commercial production. Welcome to

C 5. chemical development contract research custom synthesis cgmp API manufacturing commercial production. Welcome to C 5 chemical development contract research custom synthesis cgmp API manufacturing commercial production Welcome to ChemCon Company profile Company profile ChemCon offers outstanding chemical services

More information

1 The quality management system (QMS) is the corner stone of compliance to GMP. The QMS is made up of several documents, that when followed ensures the GMP compliance of the process, facility and company.

More information

Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice

Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice Version 8 (final) EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 S\common\legal-legislation\75-319nd81-851\91-356\eudralexvol4\Annex

More information

Quality Systems Appropriate for Extemporaneously Prepared Early Phase Clinical Trial Materials. Agenda Topics for Discussion

Quality Systems Appropriate for Extemporaneously Prepared Early Phase Clinical Trial Materials. Agenda Topics for Discussion Quality Systems Appropriate for Extemporaneously Prepared Early Phase Clinical Trial Materials Richard Hoffman, MS Eli Lilly & Co. Principal Consultant - Regulatory PDA/FDA Joint September 20 th, 2011

More information

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY VERSION 7

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY VERSION 7 EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Health systems and products Medicinal products quality, safety and efficacy Brussels, IMPORTATION OF ACTIVE SUBSTANCES FOR MEDICINAL PRODUCTS

More information

New Guidelines on Good Distribution Practice of Medicinal Products for Human Use (2013/C 68/01)

New Guidelines on Good Distribution Practice of Medicinal Products for Human Use (2013/C 68/01) Safeguarding public health New Guidelines on Good Distribution Practice of Medicinal Products for Human Use (2013/C 68/01) Tony Orme, Senior GDP Inspector Inspection, Enforcement and Standards Division

More information

Best Practices In Ensuring Quality Standards When Outsourcing To Contract Manufacturers, Licensees And Consultants

Best Practices In Ensuring Quality Standards When Outsourcing To Contract Manufacturers, Licensees And Consultants Best Practices In Ensuring Quality Standards When Outsourcing To Contract Manufacturers, Licensees And Consultants Alex D. Kanarek, PhD BioProcess Technology Consultants, Inc. Strategic Institute Quality

More information

Report on the audit of (audited National Competent Authority) done on : (date of the audit)

Report on the audit of (audited National Competent Authority) done on : (date of the audit) Reference of the document X Annexes Date Report on the audit of (audited National Competent Authority) done on : (date of the audit) By. rapporteur 1. Introduction Country information Pharmaceutical industry

More information

Harmonizing Change Control Processes Globally

Harmonizing Change Control Processes Globally Quality & Compliance Associates, LLC Harmonizing Change Control Processes Globally President Quality & Compliance Associates, LLC When We Deal In A Global Environment, How Do We Design A System That Addresses

More information

Recent Updates on European Requirements and what QPs are expected to do

Recent Updates on European Requirements and what QPs are expected to do Recent Updates on European Requirements and what QPs are expected to do QP Forum 28/29 November 2013, Lisbon Dr. Bernd Renger Modified: Georg Goestl 1 Written Conformation for API-Import Actual Status

More information

LIFE SCIENCES QAD SOLUTIONS ARE BUILT FOR LIFE SCIENCES MANUFACTURERS, BUILT FOR YOU

LIFE SCIENCES QAD SOLUTIONS ARE BUILT FOR LIFE SCIENCES MANUFACTURERS, BUILT FOR YOU QAD SOLUTIONS ARE BUILT FOR LIFE SCIENCES MANUFACTURERS, BUILT FOR YOU The global life sciences industry continues to experience dramatic change. Life sciences manufacturers remain dedicated to innovation,

More information

Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives. Barry A. Friedman, Ph.D. Consultant

Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives. Barry A. Friedman, Ph.D. Consultant Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives Barry A. Friedman, Ph.D. Consultant FDA Overview FDA is a consumer protection agency within the Department of Health & Human

More information

Pharmaceutical Wholesaler Site Inspection Checklist

Pharmaceutical Wholesaler Site Inspection Checklist Pharmaceutical Wholesaler Site Inspection Checklist Date and time of inspection: Legal business name and plant name: Location (address): Phone number: Fax number: Email address: Web site URL: Contact Person:

More information

The FDA recently announced a significant

The FDA recently announced a significant This article illustrates the risk analysis guidance discussed in GAMP 4. 5 By applying GAMP s risk analysis method to three generic classes of software systems, this article acts as both an introduction

More information

What is the correct title of this publication? What is the current status of understanding and implementation?

What is the correct title of this publication? What is the current status of understanding and implementation? GMP Rules and Guidelines in 2013 for Computer System Validation / Computerises Systems / Electronic Records and Signatures/ IT Infrastructure and Application Compliance: What is the correct title of this

More information

GRADUATE CERTIFICATE IN GOOD MANUFACTURING PRACTICE (GMP) Plan your career for tomorrow and you will be ahead of your competitors

GRADUATE CERTIFICATE IN GOOD MANUFACTURING PRACTICE (GMP) Plan your career for tomorrow and you will be ahead of your competitors GRADUATE CERTIFICATE IN GOOD MANUFACTURING PRACTICE (GMP) Plan your career for tomorrow and you will be ahead of your competitors This course is a distance-learning program that will culminate in a Graduate

More information

Clinical Trial Logistics

Clinical Trial Logistics Company Brochure Clinical Trial Logistics contents 1. 2. 3. 4. 5. 6. About us Values Facility Quality Management System Services Why PCS Clinical Trial Logistics about us MEET US PHARMA COMPLEX SOLUTIONS

More information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Public Health and Risk Assessment Pharmaceuticals Brussels, SANCO/C8/AM/sl/ares(2010)1064587 EudraLex The Rules Governing Medicinal Products

More information

CONCEPT HEIDELBERG. Pharmaceutical Quality Training. Conferences. Services.

CONCEPT HEIDELBERG. Pharmaceutical Quality Training. Conferences. Services. CONCEPT HEIDELBERG Pharmaceutical Quality Training. Conferences. Services. About Us Helping you to Comply with GMP Since our foundation on 1 April 1978, CONCEPT HEIDELBERG has been concentrating on providing

More information

Engineering Nanomedical Systems

Engineering Nanomedical Systems BME 695 November 8, 2011 Engineering Nanomedical Systems Lecture 15 GMP and issues of quality control manufacture of nanodelivery systems James F. Leary, Ph.D. SVM Endowed Professor of Nanomedicine Professor

More information

Annex 9 Guide to good storage practices for pharmaceuticals 1

Annex 9 Guide to good storage practices for pharmaceuticals 1 World Health Organization WHO Technical Report Series, No. 908, 2003 Annex 9 Guide to good storage practices for pharmaceuticals 1 1. Introduction 125 2. Glossary 126 3. Personnel 128 4. Premises and facilities

More information

Quality Management System for Active pharmaceutical Ingredients manufacturers. Integrating GMP into ISO 9001

Quality Management System for Active pharmaceutical Ingredients manufacturers. Integrating GMP into ISO 9001 Quality Management System for Active pharmaceutical Ingredients manufacturers Integrating GMP into ISO 900 December 997 Table of contents A. Acknowledgement... 3 B. Introduction... 5 C. Glossary... 8 D.

More information

Microbiology and Auditing. Don Singer

Microbiology and Auditing. Don Singer Microbiology and Auditing Don Singer ASQ Northeast Pharmaceutical GMP/Quality Conference 2011 Through the eyes of a Microbiologist Microbiology Audit = Inspection / Investigation Systematic Auditing Planning

More information

Supply Chain Challenges and Risk Management

Supply Chain Challenges and Risk Management Supply Chain Challenges and Risk Management Presented by Steve Williams Director SeerPharma P/L 21 st April 2009 PDA April 09 SW 1 Supply Chain - Some Useful Guidance cgmp Annex 8 cgmp Chapter 7 ICH Q7

More information

Conducting a Gap Analysis on your Change Control System. Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc.

Conducting a Gap Analysis on your Change Control System. Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc. Conducting a Gap Analysis on your Change Control System Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc. Standards, Regulations, Guidelines related to Change Control Management

More information

Guide to Master Formulae WHO/FWC/IVB/QSS/VQR

Guide to Master Formulae WHO/FWC/IVB/QSS/VQR WHO/FWC/IVB/QSS/VQR 2011 This guidance document GUIDE TO MASTER FORMULAE is one of a series developed by WHO/FWC/IVB Quality, Safety & Standards team upon request from the manufacturers members of the

More information

EAEPC Good Parallel Distribution Practice Guidelines for Medicinal Products

EAEPC Good Parallel Distribution Practice Guidelines for Medicinal Products EAEPC Good Parallel Distribution Practice Guidelines for Medicinal Products Due to its role in the production and handling of products related to public health, the Community pharmaceutical sector operates

More information

The Quality System for Drugs in Germany

The Quality System for Drugs in Germany The Quality System for Drugs in Germany Prof. Dr. Harald G. Schweim Head of Department for Drug Regulatory Affairs Institute for Pharmacy, University of Bonn Former President of the German Federal Institute

More information

Pharmaceutical Quality Management System: Current Concept

Pharmaceutical Quality Management System: Current Concept Pharmaceutical Quality Management System: Current Concept Neetu Dubey 1, *, Himanshu Gupta 3, R.K. Sharma 2, Nitin Dubey 1, Nidhi Dubey 4 1. IPS Academy, Indore, Madhya Pradesh, India. 2. Prestige Institute

More information

An Overview of Pharmaceutical Validation and Process Controls in Drug Development

An Overview of Pharmaceutical Validation and Process Controls in Drug Development Tropical Journal of Pharmaceutical Research, December 2002; 1 (2): 115-122 Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, Nigeria. All rights reserved. Available online at

More information

Inspections, Compliance, Enforcement, and Criminal Investigations

Inspections, Compliance, Enforcement, and Criminal Investigations Page 1 of 5 Home Inspections, Compliance, Enforcement, and Criminal Investigations Enforcement Actions Warning Letters Inspections, Compliance, Enforcement, and Criminal Investigations Jabones Pardo S.A.

More information

LIBRARY GUIDE: Pharmaceutical GMPs

LIBRARY GUIDE: Pharmaceutical GMPs LIBRARY GUIDE: Pharmaceutical GMPs Table of Contents Overview............................................................................ 3 Courses Listed by Functional Area....................................................

More information

Library Guide: Pharmaceutical GMPs

Library Guide: Pharmaceutical GMPs Library Guide: Pharmaceutical GMPs Table of Contents Overview...3 Courses Listed by Functional Area... 4 Course Descriptions: A Step-by-Step Approach to Process Validation (PHDV79)... 7 A Tour of the FDA

More information

FOOD AND DRUG LAW JOURNAL Analyzing the Laws, Regulations, and Policies Affecting FDA-Regulated Products

FOOD AND DRUG LAW JOURNAL Analyzing the Laws, Regulations, and Policies Affecting FDA-Regulated Products FOOD AND DRUG LAW JOURNAL Analyzing the Laws, Regulations, and Policies Affecting FDA-Regulated Products Enforcement Protecting the Public s Health Through the Application Integrity Policy Paula R. Katz

More information

Principles. of Pharmaceutical Facility Design. Full Time Part Time Online. www.dpseng.com.sg

Principles. of Pharmaceutical Facility Design. Full Time Part Time Online. www.dpseng.com.sg Principles of Pharmaceutical Facility Design Full Time Part Time Online www.dpseng.com.sg Contents 1. Welcome 2. Programme Overview 3. Programme Content www.dpseng.com.sg 2 Welcome Transition into a new

More information

Good Manufacturing Practices: A Synopsis of Their Role and Rationale in Today's Pharmaceutical Marketplace for Tubing

Good Manufacturing Practices: A Synopsis of Their Role and Rationale in Today's Pharmaceutical Marketplace for Tubing Good Manufacturing Practices: A Synopsis of Their Role and Rationale in Today's Pharmaceutical Marketplace for Tubing Katherine L. Ulman and Dr. Patricia Rafidison Dow Corning Healthcare About the Authors

More information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products- authorisations, European Medicines Agency Brussels, EudraLex The Rules Governing Medicinal

More information

GMP ANNEX 1 REVISION 2008, INTERPRETATION OF MOST IMPORTANT CHANGES FOR THE MANUFACTURE OF STERILE MEDICINAL PRODUCTS

GMP ANNEX 1 REVISION 2008, INTERPRETATION OF MOST IMPORTANT CHANGES FOR THE MANUFACTURE OF STERILE MEDICINAL PRODUCTS PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 032-2 8 January 2010 RECOMMENDATION GMP ANNEX 1 REVISION 2008, INTERPRETATION OF MOST IMPORTANT CHANGES FOR THE MANUFACTURE

More information

ASI 691 Prinicples of HACCP 1

ASI 691 Prinicples of HACCP 1 Prerequisite Programs: GMP s, SOP s, SSOP s HACCP Does Not Stand Alone Must be built on existing food safety programs Prerequisite Programs Definition of Prerequisite Programs- Procedures, including Good

More information

Your 4 th Emergency Service. Case Studies and Experience of Others

Your 4 th Emergency Service. Case Studies and Experience of Others Your 4 th Emergency Service Case Studies and Experience of Others Preparing for 2015 and beyond Where do we invest? Prevention and appraisal costs or failure costs? (BS6143) 2 Invest before it goes wrong

More information

ICH Public Meeting. Joseph C. Famulare. October 2, 2006. Acting Deputy Director Office of Compliance CDER / FDA Office of Compliance

ICH Public Meeting. Joseph C. Famulare. October 2, 2006. Acting Deputy Director Office of Compliance CDER / FDA Office of Compliance ICH Public Meeting October 2, 2006 Joseph C. Famulare Acting Deputy Director Office of Compliance CDER / FDA Office of Compliance The Current State of Pharmaceutical Manufacturing Inability to predict

More information

GMP Regulatory Considerations

GMP Regulatory Considerations GMP Regulatory Considerations Alain Kupferman Workshop on WO prequalification requirements for reproductive health medicines, Jakarta, October 2009 REGULATORY CONSIDERATIONS CONTAINMENT PROTECTION METODS

More information

FDA Inspection Observations The FDA 483 and Beyond. Objectives

FDA Inspection Observations The FDA 483 and Beyond. Objectives FDA Inspection Observations The FDA 483 and Beyond Presenter: David L. Chesney Vice President and Practice Lead PAREXEL Consulting, Waltham, MA Dave.chesney@parexel.com Objectives Describe history and

More information

Planning Engineering Projects management of Pharmaceutical Plants

Planning Engineering Projects management of Pharmaceutical Plants Planning Engineering Projects management of Pharmaceutical Plants Contrà S. ANNA 1/5 35012 CAMPOSAMPIERO (PD) www.tsaonline.it tel. 0039-0495792435 fax 0039-0499306065 Chemical and Pharmaceutical Engineering

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Contract Manufacturing Arrangements for Drugs: Quality Agreements DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding

More information

Guidelines for the Acceptance of Manufacturer's Quality Assurance Systems for Welding Consumables

Guidelines for the Acceptance of Manufacturer's Quality Assurance Systems for Welding Consumables (1987) Guidelines for the Acceptance of Manufacturer's Quality Assurance Systems for Welding Consumables 1. General 1.1 Introduction 1.1.1 The present guidelines are to serve as a supplement to the IACS

More information

How companies leverage quality and quality certifications to achieve competitive advantage

How companies leverage quality and quality certifications to achieve competitive advantage How companies leverage quality and quality certifications to achieve competitive advantage Eize de Boer Systems & Services Certification International Business Development Manager Pharma Supply Chain for

More information

COTS Validation Post FDA & Other Regulations

COTS Validation Post FDA & Other Regulations COTS Validation Post FDA & Other Regulations TABLE OF CONTENTS 1. Abstract 3 2. What is COTS 3 3. Why should COTS require Validation? 3 4. Risk Based Approach 4 5. Validation Approach 6 6. Applicable Regulations

More information

Monitoring manufacturing, production and storage environments in the pharmaceutical industry

Monitoring manufacturing, production and storage environments in the pharmaceutical industry Application Description AD/RandC/005-EN Monitoring manufacturing, production and storage environments in the pharmaceutical industry - Provides independent verification and validation of the manufacture,

More information

Impact of Formula-Based ERP Applications on Pharmaceutical Manufacturers

Impact of Formula-Based ERP Applications on Pharmaceutical Manufacturers Impact of Formula-Based ERP Applications on Pharmaceutical Manufacturers Executive Summary Whether you re in the process of re-evaluating your existing ERP application or looking to replace your spreadsheets,

More information

Regulatory oversight of drug clinical trial in China. Wang Jianan CFDI-CFDA ,Berlin

Regulatory oversight of drug clinical trial in China. Wang Jianan CFDI-CFDA ,Berlin Regulatory oversight of drug clinical trial in China Wang Jianan CFDI-CFDA wjn@ccd.org.cn 2014.9,Berlin 1 Outline Brief introduction of CFDA/CFDI Relevant laws and regulations Supervision of drug clinical

More information

Validation Consultant

Validation Consultant Personal Data Name Title Validation Consultant Contact jsb-validierung Zwischen den Bächen 9 D 79618 Rheinfelden Tel: +49 7623 79 49 82 Mobile: +49 172 737 84 86 E-Mail: Internet: jsb-val@online.de http://www.jsb-validierung.de

More information

New Investigator Collaborations and Interactions: Regulatory

New Investigator Collaborations and Interactions: Regulatory Your Health and Safety... Our priority Votre santé et votre Securité notre priorité New Investigator Collaborations and Interactions: Regulatory NCIC Clinical Trials Group New Investigator Clinical Trials

More information

CUSTOM PEPTIDE SYNTHESIS AT BACHEM

CUSTOM PEPTIDE SYNTHESIS AT BACHEM CUSTOM SYNTHESIS CUSTOM PEPTIDE SYNTHESIS AT BACHEM A strong commitment to quality is the basis of our long-standing market leadership We have the capability to synthesize peptides in mg to kg-scale which

More information

Overview of Pre-Approval Inspections

Overview of Pre-Approval Inspections Overview of Pre-Approval Inspections Presented by: Kelli F. Dobilas NWJ-DO Pre-Approval Manager Pre-Approval Drug Inspections What are Pre-Approval Inspections? One of the last reviews of the drug approval

More information

Documenting Distribution Operations: FDA Validation Beyond the Laboratory and Manufacturing Facility

Documenting Distribution Operations: FDA Validation Beyond the Laboratory and Manufacturing Facility Documenting Distribution Operations: FDA Validation Beyond the Laboratory and Manufacturing Facility Kellie Wittman, Tompkins Associates September 2009 www.tompkinsinc.com Contents Introduction 3 Why bother

More information

PHARMACEUTICAL REFERENCE STANDARDS

PHARMACEUTICAL REFERENCE STANDARDS PHARMACEUTICAL REFERENCE STANDARDS 11 th International Symposium organised by the European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe 3-4 September 2012, Strasbourg,

More information

10 common GMP challenges facing Maintenance departments in pharmaceutical plants

10 common GMP challenges facing Maintenance departments in pharmaceutical plants 10 common GMP challenges facing Maintenance departments in pharmaceutical plants This white paper lists the GMP compliance problems often seen within the maintenance departments of pharmaceutical operations.

More information

World Health Organization Prequalification of Medicines

World Health Organization Prequalification of Medicines Dr André van Zyl World Health Organization Prequalification of Medicines Manufacturers meeting April 2011 Head of Inspections vanzyla@who.int 1 WHO GMP In this presentation: Background and Introduction

More information

There is no Silver Bullet to complying with the US FDA GMPs by Alan Schwartz

There is no Silver Bullet to complying with the US FDA GMPs by Alan Schwartz There is no Silver Bullet to complying with the US FDA GMPs by Alan Schwartz Recently, we participated in a seminar on United States (US) Food and Drug Administration (FDA) regulations to the Hebei Pharmaceutical

More information

On-Site GMP Training GMP COMPLIANCE TECHNICAL

On-Site GMP Training GMP COMPLIANCE TECHNICAL PharmaNet On-Site GMP Training GMP COMPLIANCE TECHNICAL 284 E Lake Mead Pkwy Suite C-278 Henderson, NV 89015 Phone: 702-558-0094 Fax: 702-558-0079 www.gmpseminars.com Key to Level of Program Level A: Program

More information

Guidance for Industry Circumstances that Constitute Delaying, Denying, Limiting, or Refusing a Drug Inspection

Guidance for Industry Circumstances that Constitute Delaying, Denying, Limiting, or Refusing a Drug Inspection Guidance for Industry Circumstances that Constitute Delaying, Denying, Limiting, or Refusing a Drug Inspection U.S. Department of Health and Human Services Food and Drug Administration Office of Regulatory

More information

Corrective and Preventive Actions

Corrective and Preventive Actions Corrective and Preventive Actions A Five Step Approach Topics to Be Covered What is CAPA? Governing authority Five steps to a good CAPA process Where companies have difficulty Example citations Recap What

More information

FDA 21 CFR Part 11 Electronic records and signatures solutions for the Life Sciences Industry

FDA 21 CFR Part 11 Electronic records and signatures solutions for the Life Sciences Industry FDA 21 CFR Part 11 Electronic records and signatures solutions for the Life Sciences Industry The Rule 21 CFR Part 11 Handwritten signature means the scripted name or legal mark of an individual handwritten

More information

COMMISSION DIRECTIVE 2003/94/EC

COMMISSION DIRECTIVE 2003/94/EC L 262/22 COMMISSION DIRECTIVE 2003/94/EC of 8 October 2003 laying down the principles and guidelines of good manufacturing practice in respect of medicinal products for human use and investigational medicinal

More information

Valentina Gualato, Ph.D. Process Development Scientist

Valentina Gualato, Ph.D. Process Development Scientist COMPANY PRESENTATION Quality and Innovation Valentina Gualato, Ph.D. Process Development Scientist MISSION areta international is a biotech company dedicated to the contract development and manufacturing

More information

Managing the Cost of Compliance in Pharmaceutical Operations 1

Managing the Cost of Compliance in Pharmaceutical Operations 1 Frances Bruttin and Dr. Doug Dean IBM Business Consulting Services Pharmaceutical Sector Aeschenplatz 2 CH-4002 Basel Switzerland +41-58-333-7687 (tel) +41-58-333-8117 (fax) Managing the Cost of Compliance

More information

Corden Pharma Latina S.p.A. 5/20/16

Corden Pharma Latina S.p.A. 5/20/16 Corden Pharma Latina S.p.A. 5/20/16 Department of Health and Human Services Public Health Service Food and Drug Administration Silver Spring, MD 20993 Via UPS Warning Letter 320-16-14 Return Receipt Requested

More information

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7: NON-STERILE PROCESS VALIDATION

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7: NON-STERILE PROCESS VALIDATION April 2013 RESTRICTED 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES:

More information

Making SOP Training More Effective

Making SOP Training More Effective By David Peterson, Director, GMP and Quality Systems, UL EduNeering SOPs are critical to efficient operations, quality control and regulatory compliance. This paper reviews best practices for the Life

More information

ACINO SWITZERLAND. Delivering Health Ensuring Effective Relief

ACINO SWITZERLAND. Delivering Health Ensuring Effective Relief ACINO SWITZERLAND Delivering Health Ensuring Effective Relief Content CEO Letter 03 Acino at a glance 05 Our brand»acino Switzerland«06 Commercial Operations 08 Out-licensing 10 Contract Manufacturing

More information

tdodds@jeffyuen.com 714 282-1014 Jeff Yuen and Associates, Inc. PO Box 6026 Orange, CA 92863 Terri Dodds CAPT. (RET) TERRI L.

tdodds@jeffyuen.com 714 282-1014 Jeff Yuen and Associates, Inc. PO Box 6026 Orange, CA 92863 Terri Dodds CAPT. (RET) TERRI L. SKILLS/SPECIAL QUALIFICATIONS: Regulatory Expertise: Technical Expertise: CAPT. (RET) TERRI L. DODDS - BSN, RN Former Public Health Service (PHS) Officer with 16 years of FDA experience in Pharmaceuticals,

More information

Guidance on Qualification of existing facilities, systems, equipment and utilities

Guidance on Qualification of existing facilities, systems, equipment and utilities QUALIFICATION_EXISTING_EQUIPMENT_FINAL page 1 / 16 1. Acknowledgement...3 2. Introduction...3 3. Scope...4 4. Regulatory requirements...4 5. Guidance...4 5.1 Risk Assessment... 4 5.2 Procedure... 7 5.3

More information

Hong Kong Guide to Good Manufacturing Practice for the Secondary Packaging of Pharmaceutical Products

Hong Kong Guide to Good Manufacturing Practice for the Secondary Packaging of Pharmaceutical Products Hong Kong Guide to Good Manufacturing Practice for the Secondary Packaging of Pharmaceutical Products Version 1.3 Drug Office, Department of Health. Contents list 1. QUALITY MANAGEMENT... 4 2. PERSONNEL...

More information

We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards.

We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards. Inspection Report We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards. Eastham Walk In Centre Eastham Clinic, Eastham Rake, Eastham,

More information

Regulation and Risk Management of Combination Products

Regulation and Risk Management of Combination Products Regulation and Risk Management of Combination Products Katherine Ulman Associate Scientist Global Regulatory Compliance Manager Dow Corning Healthcare Jim Curtis Senior Specialist, Healthcare Applications

More information

(COMPANY LOGO) CGMP COMPUTERIZED SYSTEM VENDOR AUDIT QUESTIONNAIRE

(COMPANY LOGO) CGMP COMPUTERIZED SYSTEM VENDOR AUDIT QUESTIONNAIRE 1. GENERAL COMPANY INFORMATION (COMPANY LOGO) 1.1 Name Address Years in Business Number of Employees Services Performed or Products Manufactured Prior Experience with (Company Name) 1.2 Please provide

More information

B i o s o l u t i o n s

B i o s o l u t i o n s B i o s o l u t i o n s Implementation of pharmatracker TM : A case study Prepared by Ocimum Biosolutions Ocimumbio Solutions August 2006 All rights reserved. 2 B i o s o l u t i o n s an ISO 9001:2000

More information

Public Cord Blood Bank

Public Cord Blood Bank The The Public Cord Blood Bank Page 1 of 21 TABLE OF CONTENTS INTRODUCTION... 3 WHAT ARE GOOD MANUFACTURING PRACTICES?... 5 1 TOTAL QUALITY... 7 2 PREMISES... 8 3 EQUIPMENT AND MATERIAL... 9 4 PERSONNEL...

More information

Lean Process Improvements for the GMP Laboratory

Lean Process Improvements for the GMP Laboratory Lean Process Improvements for the GMP Laboratory ITRODUCTIO Pharmaceutical manufacturing costs the industry approximately $90 billion each year and represents twice the expenditure of research and development.

More information

PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013)

PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013) January 2013 RESTRICTED PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013) DRAFT FOR COMMENTS Please address any comments on this proposal

More information